ILOTYCIN GLUCEPTATE Drug Patent Profile
✉ Email this page to a colleague
When do Ilotycin Gluceptate patents expire, and what generic alternatives are available?
Ilotycin Gluceptate is a drug marketed by Dista and is included in one NDA.
The generic ingredient in ILOTYCIN GLUCEPTATE is erythromycin gluceptate. There are one hundred and three drug master file entries for this compound. Additional details are available on the erythromycin gluceptate profile page.
Summary for ILOTYCIN GLUCEPTATE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 9 |
Patent Applications: | 593 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ILOTYCIN GLUCEPTATE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for ILOTYCIN GLUCEPTATE
US Patents and Regulatory Information for ILOTYCIN GLUCEPTATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dista | ILOTYCIN GLUCEPTATE | erythromycin gluceptate | INJECTABLE;INJECTION | 050370-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Dista | ILOTYCIN GLUCEPTATE | erythromycin gluceptate | INJECTABLE;INJECTION | 050370-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Dista | ILOTYCIN GLUCEPTATE | erythromycin gluceptate | INJECTABLE;INJECTION | 050370-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |